SCHEMBL12468333

SCHEMBL12468333

O=C(O)N1CC[C@H]([C@H](CCSc2ccccc2)Oc2ccc(C(F)(F)F)cc2)C1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
CCR5 P51681 1/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A2 P23975 1/20 0.39
HTR1A P08908 4/20 0.38
LIPE Q05469 1/20 0.38
EPHX2 P34913 1/20 0.38
ALDH1A1 P00352 2/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ENPP2 Q13822 1/20 0.37
MDM2 Q00987 1/20 0.37
SLC6A9 P48067 2/20 0.37
SCN1A P35498 2/20 0.36
SCN5A Q14524 2/20 0.36
SCN9A Q15858 2/20 0.36
HRH3 Q9Y5N1 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1279861 0.90 TACR1 (0.44) SLC6A9SCN9A
SCHEMBL1280207 0.90 TACR1 (0.44) SLC6A9SCN9A
SCHEMBL16380488 0.90 TACR1 (0.44) SLC6A9SCN9A
SCHEMBL1279865 0.90 TACR1 (0.44) SLC6A9SCN9A
SCHEMBL1280205 0.90 TACR1 (0.44) SLC6A9SCN9A
SCHEMBL15428476 0.80 SLC6A4 (0.41) CCR5SLC6A4SLC6A2LIPEEPHX2
SCHEMBL3967738 0.74 PPARG (0.62) PPARGPPARASLC6A4SLC6A2SLC6A9
SCHEMBL1689415 0.73 MMP13 (0.43) LIPEEPHX2
SCHEMBL14837995 0.73 MMP13 (0.43) LIPEEPHX2
SCHEMBL9108211 0.73 MMP13 (0.45) LIPEEPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627630-A1 SEROTONIN REUPTAKE INHIBITORS Theravance, Inc. (US) 2013-08-21 EP disclosed
WO-2012051103-A1 SEROTONIN REUPTAKE INHIBITORS THERAVANCE, INC. (US) 2012-04-19 WO disclosed